Picture Berlin Partner Hotspot for Startups 650x80px
Document › Details

Aelis Farma S.A.. (2/15/22). "Press Release: Aelis Farma, a Biopharmaceutical Company Developing a New Generation of Drugs for Brain Diseases, Announces the Success of Its Initial Public Offering and Raises approximately €25 Million on Euronext Paris [No

Region Region Paris
  Country France
Organisations Organisation Aelis Farma S.A.
  Organisation 2 Euronext Paris S.A.
  Group Euronext (Group)
Products Product drug development
  Product 2 investment banking
Person Person Piazza, Pier Vincenzo (Aelis Farma 201912 CEO + INSERM Neurocentre Magendie Bordeaux)

Record changed: 2022-02-17


Picture [iito] Fighting Customers 650x100px

More documents for Aelis Farma S.A.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture Berlin Partner Bionnale the Annual Life Sciences Event 650x80px

» top